The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.00
Bid: 16.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.25%)
Open: 16.50
High: 16.50
Low: 16.50
Prev. Close: 16.50
INSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal, Loan Conversion, New Project Win & TVR

15 Nov 2023 07:00

RNS Number : 4627T
Insig AI Plc
15 November 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

15 November 2023

Insig AI plc

("Insig AI" or the "Company")

Disposal, Conversion of Convertible Loan and Related Party Transactions, New Project Win and Total Voting Rights

Insig AI plc (AIM: INSG), the data science and machine learning group, is pleased to announce the disposal of its legacy subsidiaries, Sport in Schools Limited ("Sport in Schools") and The Elms Group Limited ("Elms Group") for a total consideration of £500,000 (the "Disposal"), as well as a new project win.

Disposal of Sports in Schools Limited and The Elms Group Limited

On 14 November 2023, the Company's 85.87% owned subsidiary, Pantheon Leisure plc ("Pantheon"), entered into a sale agreement for Sports in Schools and Elms Group with Haygreen Limited for a total cash consideration payable of £300,000 (the "Cash Consideration"). Haygreen Limited is a newly incorporated company wholly owned by Jason O'Connor, a current director of Sports in Schools.

Sports in Schools generated a profit before tax of approximately £31,000 during the year ended 31 March 2023 whilst Elms Group generated a loss before tax of approximately £12,000 during the same period.

Pursuant to the Disposal and in addition to the Cash Consideration, Sports in Schools has declared a dividend payable to Patheon of approximately £262,000 of which approximately £210,000 will be used by Pantheon to partially settle an intra-group loan provided by Insig AI plc. The remaining £52,000 will be used by Pantheon to fully settle an intra-group loan directly with Sport in Schools.

Insig AI will use the Cash Consideration for general working capital purposes.

As previously announced on 12 September 2022, Richard Bernstein entered into a convertible loan agreement with the Company for a total consideration of £0.75 million, secured against the ordinary shares of Westside Sports Limited owned by the Company, which had interests in Ultimate Player Limited, Pantheon Leisure plc, Sports in Schools Limited and The Elms Group Limited. Upon completion of the Disposal, Richard Bernstein has agreed to revise the terms of the Convertible Loan including releasing the security held over West Sports Limited.

Related Party Transactions

The Disposal to Haygreen Limited, a company controlled by a related party of the Company will constitute a related party transaction under the AIM Rules. Under AIM Rule 13, all the directors of Insig AI (the "Directors") are considered to be independent in respect of the Disposal. Having consulted with the Company's nominated adviser, the Directors consider that the terms of the Disposal are fair and reasonable insofar as the Company's shareholders are concerned.

Following the Disposal, the Company and Mr Bernstein have agreed to revised terms for the Convertible Loan which includes the release of security over Westside Sports Limited and a new conversion price of 20.0 pence per ordinary share of 1 pence each in the Company ("Ordinary Share"), being a 21.2 per cent. premium to the closing price on 14 November 2023. The Directors (excluding Richard Bernstein), having consulted with Zeus Capital Limited, the Company's nominated adviser, consider that the terms of the Convertible Loan are fair and reasonable insofar as the Company's shareholders are concerned.

Conversion of Convertible Loan and Total Voting Rights

The Company has also received notice from Richard Bernstein to convert the current balance of the Convertible Loan, being £785,076 (inclusive of accrued interest) into 3,925,380 Ordinary Shares at a conversion price of 20.0 pence per ordinary share (the "Conversion").

Following the Conversion, Mr Bernstein will be interested in 19,925,380 Ordinary Shares in the Company which equates to 18.4% of the total voting rights of the Company.

As a result of the Conversion, an application has been made to the London Stock Exchange for admission of the 3,925,380 Ordinary Shares to trading on AIM ("Admission"). It is expected that Admission will become effective on 21 November 2023.

Following Admission, the total number of Ordinary Shares in issue will be 109,601,025. The Company currently holds 1,205,888 Ordinary Shares in treasury. As such, the total number of voting rights in the Company will be 108,395,137.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules. 

New project win

The Company is also pleased to announce that it has entered into a commitment to provide a scalable and automated solution to a US and European based provider of Collateralised Loan Obligations and structured credit products with assets under management of more than £3 billion.

The commitment of work is for an initial sum of £60,000 to commence immediately, with the opportunity for further follow-on projects. Insig AI will provide a central database allowing for the development and application of machine learning methods. The commitment of work also involves integrating Insig AI's data analytics software into the launch of a potential new fund, which could provide longer term recurring revenue streams for the Company.

 

Executive Chairman, Richard Bernstein commented: "We are pleased to have disposed of the legacy business at a multiple of more than 25 times historic pre-tax profits. This enables us to fully focus on our machine learning capabilities. In addition, whilst an initial £60,000 customer commitment is welcome, we're excited to now have the opportunity to substantially develop and deepen this new client relationship."

 

 

 

-END-

Insig AI plc

Colm McVeigh, CEO 

 

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold

 

+44 (0) 203 829 5000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name 

 

Richard Bernstein

2

 

Reason for the notification

 

a)

 

Position/status

  

Executive Chairman

b)

 

Initial notification /Amendment 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Insig AI plc

b)

 

LEI

21380098CKBAG1NWCD98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence each

Identification code

GB00BYV31355

b)

 

Nature of the transaction

Conversion of convertible loan facility

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

20.0 pence

3,925,380

 

d)

 

Aggregated information

N/A single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

14 November 2023

f)

 

Place of the transaction 

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIBTTMTMBTAJ
12
Date   Source Headline
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSFunding facility, share allotment & PDMR dealing
2nd Apr 20247:00 amRNSTrading update & equity funding facility proposal
28th Dec 20237:00 amRNSInclusion within UN Environment Programme Tool
22nd Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSInterim results
28th Nov 20237:00 amRNSAppointment of investor relations adviser and TVR
27th Nov 20237:00 amRNSCorporate development adviser and TVR
15th Nov 20237:00 amRNSDisposal, Loan Conversion, New Project Win & TVR
30th Oct 20237:00 amRNSNew Product Launch
28th Sep 20237:00 amRNSAppointment of Strategic Adviser and TVR
15th Sep 20233:56 pmRNSResult of AGM
15th Sep 20237:00 amRNSAGM Statement
30th Aug 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20237:00 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSFinal Results, Posting of Report and Notice of AGM
1st Aug 20234:42 pmRNSChange of Registered Office
31st Jul 20235:30 pmRNSTotal Voting Rights
4th Jul 20237:00 amRNSRevision of Convertible Loan Facility Agreement
19th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Apr 20237:00 amRNSDeath of Director
24th Apr 20237:02 amRNSEquity subscription
24th Apr 20237:01 amRNSInsig AI Data & Technology Collaboration with FCA
24th Apr 20237:00 amRNSTrading and operations update
9th Mar 20237:00 amRNSInsig AI showcase Generative AI Product Capability
6th Feb 20237:00 amRNSGenerative AI Product Capability
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSConvertible Loan Facility Drawdown
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector Dealing
22nd Dec 20227:00 amRNSRevision of Convertible Loan Facility Agreements
21st Dec 20227:00 amRNSDirectors gift shares to Company treasury & TVR
19th Dec 20227:00 amRNSInterim Results
8th Nov 20227:00 amRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNSNew Contract Win
3rd Nov 20227:00 amRNSTrading update
26th Oct 20227:00 amRNSConvertible Loan Facility drawdown
17th Oct 20227:00 amRNSPartnership agreement with BRAIN
12th Oct 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
30th Sep 202212:13 pmRNSResult of Annual General Meeting & General Meeting
30th Sep 20227:00 amRNSContract win
26th Sep 20227:00 amRNSConvertible Loan Facility drawdown
20th Sep 20227:00 amRNSChange of Registered Office
12th Sep 20227:00 amRNSConvertible Loan Facility Agreement
9th Sep 20227:00 amRNSFinal Results, Posting of Report and Notice of GM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.